Abstract
Twins studies indicate that many individual factors are associated with genetic polymorphisms in tobacco use, dependence vulnerability, and the ability to quit smoking. Opioid receptor delta-type 1 (OPRD1) is one of the most important genes in the opioid pathway. Therefore, the current study aimed to investigate the association of variants located in the intron 1 of the OPRD1 gene, including rs2236857, rs2236855, and rs760589, with susceptibility to nicotine dependence among northern Iranians. DNA of 426 individuals, including 224 smokers and 202 healthy people, were extracted with the salting-out standard technique, qualified with Agarose gel, then quantified with Nanodrop, and finally genotyped by Amplification Refractory Mutation System (ARMS) PCR. All statistical analyses were performed by SNPAlyze version 8.1 and SPSS version 20. Results revealed no significant association of all three studied variants with the susceptibility to nicotine dependence in any models of inheritance. However, there were five haplotypes with an overall frequency higher than 0.05; no significant impact of any of them on nicotine dependence was observed. Altogether, rs2236857, rs2236855, and rs760589 were not associated with nicotine dependence among northern Iranians.
Similar content being viewed by others
Data Availability
The authors have complete access to the data and material, and the data and materials reported in the paper are completely reliable.
References
Albonaim A, Fazel H, Sharafshah A, Omarmeli V, Rezaei S, Ajamian F, Keshavarz P (2017) Association of OPRK1 gene polymorphisms with opioid dependence in addicted men undergoing methadone treatment in an Iranian population. J Addict Dis 36(4):227–235
Albonaim A, Sharafshah A, Keshavarz P (2020) Haplotype-based association study of Opioid Receptor Kappa-type 1 (OPRK1) gene polymorphisms with nicotine dependence among male smokers. Br J Biomed Sci
Berrendero F, Kieffer BL, Maldonado R (2002) Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in μ-opioid receptor knock-out mice. J Neurosci 22(24):10935–10940
Berrendero F, Mendizábal V, Robledo P, Galeote L, Bilkei-Gorzo A, Zimmer A, Maldonado R (2005) Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. J Neurosci 25(5):1103–1112
Berrendero F, Robledo P, Trigo JM, Martín-García E, Maldonado R (2010) Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system. Neurosci Biobehav Rev 35(2):220–231
Brookman RR, Haddad LM, Winchester JF (1984) (Eds.) Clinical Management of Poisoning and Drug Overdose, WB Saunders, Philadelphia (1983) ISBN: 0–7216–4447–3: Elsevier
Dick DM, Foroud T (2003) Candidate genes for alcohol dependence: a review of genetic evidence from human studies. Alcoholism: Clin Exp Res 27(5):868–879
Fujioka K, Shibamoto T (2006) Determination of toxic carbonyl compounds in cigarette smoke. Environmental Toxicology: An International Journal 21(1):47–54
Galeote L, Berrendero F, Andreea Bura S, Zimmer A, Maldonado R (2009) Prodynorphin gene disruption increases the sensitivity to nicotine self-administration in mice. Int J Neuropsychopharmacol 12(5):615–625
Göktalay G, Cavun S, Levendusky MC, Hamilton JR, Millington WR (2006) Glycyl-glutamine inhibits nicotine conditioned place preference and withdrawal. Eur J Pharmacol 530(1–2):95–102
Haberstick BC, Timberlake D, Ehringer MA, Lessem JM, Hopfer CJ, Smolen A, Hewitt JK (2007) Genes, time to first cigarette and nicotine dependence in a general population sample of young adults. Addiction 102(4):655–665
Heath A, Kirk K, Meyer J, Martin N (1999) Genetic and social determinants of initiation and age at onset of smoking in Australian twins. Behav Genet 29(6):395–407
Holford P, Braly J, Miller D (2010) How To Quit Without Feeling S** T: The fast, highly effective way to end addiction to caffeine, sugar, cigarettes, alcohol, illicit or prescription drugs: Hachette UK
Ismayilova N, Shoaib M (2010) Alteration of intravenous nicotine self-administration by opioid receptor agonist and antagonists in rats. Psychopharmacology 210(2):211–220
Kendler KS, Neale M, Sullivan P, Corey L, Gardner C, Prescott C (1999) A population-based twin study in women of smoking initiation and nicotine dependence. Psychol Med 29(2):299–308
Kryger AH (2004) Listen To Your Hormones: A Doctor’s Guide To Sex. WellnessMD Publications, Love And Hormones-especially For Men
Levran O, Londono D, O’hara K, Nielsen D, Peles E, Rotrosen J, Ott J (2008) Genetic susceptibility to heroin addiction: a candidate gene association study. Genes, Brain and Behav 7(7):720–729
Li MD, Cheng R, Ma JZ, Swan GE (2003) A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 98(1):23–31
Liu X, Jernigan C (2011) Activation of the opioid μ1, but not δ or κ, receptors is required for nicotine reinforcement in a rat model of drug self-administration. Prog Neuropsychopharmacol Biol Psychiatry 35(1):146–153
Lynch BS, Bonnie RJ (1994) Growing up tobacco free: preventing nicotine addiction in children and youths: Nat Acad
Maes HH, Neale MC, Kendler KS, Martin NG, Heath AC, Eaves LJ (2006) Genetic and cultural transmission of smoking initiation: an extended twin kinship model. Behav Genet 36(6):795–808
Maes HH, Sullivan PF, Bulik CM, Neale MC, Prescott CA, Eaves LJ, Kendler KS (2004) A twin study of genetic and environmental influences on tobacco initiation, regular tobacco use and nicotine dependence. Psychol Med 34(7):1251–1261
McCarthy MJ, Zhang H, Neff NH, Hadjiconstantinou M (2011) Desensitization of δ-opioid receptors in nucleus accumbens during nicotine withdrawal. Psychopharmacology 213(4):735–744
Miller S, Dykes D, Polesky H (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215
Nelson EC, Lynskey MT, Heath AC, Wray N, Agrawal A, Shand FL, Schrage AJ (2014) Association of OPRD1 polymorphisms with heroin dependence in a large case-control series. Addiction biology 19(1):111–121
Organization WH (2011) WHO report on the global tobacco epidemic, 2011: warning about the dangers of tobacco. World Health Organization, Geneva
Ray R, Ruparel K, Newberg A, Wileyto EP, Loughead JW, Divgi C, Lerman C (2011) Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. Proc Natl Acad Sci 108(22):9268–9273
Rodgman A, Green CR (2003) Toxic chemicals in cigarette mainstream smoke-hazard and hoopla. Beiträge zur Tabakforschung International/Contributions to Tobacco Research 20(8):481–545
Rogge WF, Hildemann LM, Mazurek MA, Cass GR, Simoneit BR (1994) Sources of fine organic aerosol. 6. Cigaret smoke in the urban atmosphere. Env Sci Tech 28(7):1375–1388
Rose RJ, Broms U, Korhonen T, Dick DM, Kaprio J (2009) Genetics of smoking behavior Handbook of behavior genetics (pp. 411–432) Springer
Sharafshah A, Fazel H, Albonaim A, Omarmeli V, Rezaei S, Mirzajani E, Keshavarz P (2017) Association of OPRD1 gene variants with opioid dependence in addicted male individuals undergoing methadone treatment in the north of Iran. J Psychoactive Drugs 49(3):242–251
Sullivan PF, Kendler KS (1999) The genetic epidemiology of smoking. Nicotine & Tobacco Res 1(Suppl_2) S51-S57
Thorgeirsson TE, Gudbjartsson DF, Surakka I, Vink JM, Amin N, Geller F, Walter S (2010) Sequence variants at CHRNB3–CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet 42(5):448
Trigo JM, Zimmer A, Maldonado R (2009) Nicotine anxiogenic and rewarding effects are decreased in mice lacking β-endorphin. Neuropharmacology 56(8):1147–1153
True WR, Xian H, Scherrer JF, Madden PA, Bucholz KK, Heath AC, Tsuang M (1999) Common genetic vulnerability for nicotine and alcohol dependence in men. Arch Gen Psychiatry 56(7):655–661
Vink JM, Willemsen G, Boomsma DI (2005) Heritability of smoking initiation and nicotine dependence. Behav Genet 35(4):397–406
Walters CL, Cleck JN, Kuo Y-C, Blendy JA (2005) μ-Opioid receptor and CREB activation are required for nicotine reward. Neuron 46(6):933–943
Wolz L, Krause G, Scherer G (2002) The comet assay with MCL-5 cells as an indicator of genotoxic treatment with chemicals and cigarette smoke condensate. Altern Lab Anim 30(3):331–339
Acknowledgments
We are very thankful from our colleagues in the Cellular and Molecular Research Center, especially Dr. Nozhat Zebardast for her precious supports and helps.
Author information
Authors and Affiliations
Contributions
Mr. Alireza Sharafshah did all of experimental section of this research; also, he wrote some section of the paper including “Methods” and “Discussion” sections. Dr. Bahram Soltani had a full-time supervision on the experiment parts of the research and was being involved with the design of the research. Dr. Parvaneh Keshavarz was the main designer of the research, with full supervision on both experimental and writing parts of the paper; also, she wrote the majority of the paper.
Corresponding author
Ethics declarations
Ethical Approval
All participants consented to take part in a process approved by the Ethics Committee for Human Genome/Gene Research [IR.GUMS.REC.1396.532], and it is certified that the study is performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Consent for Publication
The authors affirm that human research participants provided informed consent for publication of their genomic data from the blood samples.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sharafshah, A., Soltani, B. & Keshavarz, P. Association Study of Opioid Receptor Delta-Type 1 (OPRD1) Gene Variants with Nicotine Dependence in an Iranian Population. J Mol Neurosci 71, 1301–1305 (2021). https://doi.org/10.1007/s12031-020-01757-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-020-01757-8